Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
offer A stimulating learning environment. Here post-docs and professors outnumber PhD students. That translates into access and close collaborations with some of the brightest ICT researchers, giving you
-
More info on the PhD project The TOBI lab (Translational Onco-genomics and Bio-Informatics) has an open position for a highly motivated biomedical researcher with expertise and interest in
-
the imec-Vision Lab (image reconstruction, processing, and analysis), the Bio-Imaging Lab (preclinical neuro-MRI), and the Laboratory of Cell Biology and Histology (cell biology and advanced microscopy
-
towards cancer and has been linked to initiation, progression, and poor prognosis of colorectal cancer. Adenocarcinomas also overexpress transmembrane mucins to exploit their role in promoting tumour cell
-
guided and supported by post-docs and senior researchers, in Luxembourg and from our international network of collaborators. You will be spending time also in Cambridge and Lisbon. For further information
-
(genome sequencing), bioinformatics and single-cell (microscopy, microfluidics, FACS) analyses of E. coli bacteria and will be centred around the following themes: Pathways involved in robustness against de
-
The Faculty of Engineering, Department Elektronica en informatica, Research Group Electronics and Informatics: Research – Development - Innovation is looking for a PhD-student with a doctoral grant
-
on cancer metastasis and novel metabolic pathways. We exploit mouse models, genetic engineering, metabolomics and single cell & spatial multi-omics analysis to gain groundbreaking insights into metabolism as
-
on cancer metastasis and novel metabolic pathways. We exploit mouse models, genetic engineering, metabolomics and single cell & spatial multi-omics analysis to gain groundbreaking insights into metabolism as
-
the preparation and defence of a PhD thesis in the field of Medical Sciences. More specific, you will work on the validation of predictive peptide biomarkers to classify non-small cell lung cancer (NSCLC) patients